In our study, we demonstrated that ZMAT1 was down-regulated in PDAC and the expression of ZMAT1 was correlated with tumor differentiation, tumor stage, and patient survival, indicating it served as a predictive biomarker for PDAC. The gene discussed is ZMAT1; the disease is neoplasm.